Skip to main content

Merck has announced plans to acquire Cidara Therapeutics, the developer of a promising experimental flu treatment, in a deal valued at $9.2 billion.

Merck to Acquire Cidara Therapeutics in $9.2 Billion Deal

Marty Makary and Vinay Prasad of the FDA have proposed a streamlined framework for developing CRISPR gene-editing treatments on demand. This approach promises faster delivery of personalized medicines, potentially transforming care for families in need of urgent genetic therapies. Experts weigh in on the innovation's impact and future possibilities in gene-editing medicine development.

Expert Perspectives on Streamlining CRISPR Gene-Editing Therapies

In the latest edition of STAT's Health Tech newsletter, Pfizer reveals its developing initiatives in digital health technology, highlighting the company's growing commitment to innovation in healthcare. This update includes insights into Pfizer's strategic direction and other relevant health tech industry news.

Pfizer's Emerging Focus on Digital Health Innovations

AbbVie is concluding its ten-year collaboration with Calico Life Sciences, a biotech firm funded by Alphabet that specializes in aging research. Alongside this, AbbVie has announced layoffs affecting its scientific workforce.

AbbVie Ends Partnership with Google-Backed Calico Life Sciences, Lays Off Research Staff

This week's AI Prognosis newsletter covers insights on Microsoft's approach to 'humanist superintelligence,' updates on AI vendors working with Medicare, and other relevant news in the field of artificial intelligence.

AI Perspectives: Microsoft's Vision, Medicare's AI Vendors, and More

Medicare has announced it will pay more than $1,000 for artificial intelligence to analyze heart scans, sparking debate over whether this cost is too high.

Medicare Allocates Over $1,000 for AI-Based Heart Scan Analysis: Is It Justified?

Pfizer's acquisition of Metsera could significantly influence the dynamics of mergers and acquisitions within the biotech sector.

Impact of Pfizer's Acquisition of Metsera on Biotech M&A Landscape


UnitedHealthcare has announced it will cease reimbursing physicians for remotely monitoring patient data collected at home, a move that conflicts with existing Medicare policies.


Is the turmoil within the FDA truly responsible for drugmakers' recent setbacks? The situation is complex and cannot be solely attributed to the agency's internal issues.


In the latest edition of STAT's Health Tech newsletter, the FDA's digital health advisory committee is set to discuss potential regulations for therapy chatbots, highlighting the agency's focus on digital health innovation and patient safety.